Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Published by The Insight Partners Product code 936591
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography
Published: April 29, 2020 Content info: 100 Pages
Description

Asia Pacific, the Biodefense Market, is anticipated to reach US$ 1,520.67 Mn in 2027 from US$ 723.70 Mn in 2019. The market is projected to grow with a CAGR of 9.8% from 2020-2027.

The Biodefense Market is growing primarily due to the presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. Restraining factors, such as low R&D funding by government in developing and underdeveloped economies likely to damage the growth of the market in the coming years. Additionally, increased adoption of technologies and predictive analytics to reshape biodefense market are likely to increase the growth of the biopharmaceuticals contract manufacturing in the forecast period.

Biodefense is referred to the measures taken to restore biosecurity of a group of organisms that are, or may be, subject to biological threats or infectious diseases. It is an effective public health care system with strong disease surveillance and rapid actions designed to counter biological threats, to limit the spread of disease and provide surge medical care.

Every year, the government is spending heavily on the R&D of vaccines to stay prepared for any bioterrorism attacks. For instance, in Japan reinforcing public health biopreparedness and preventive measures (pathogen control) were followed by enhancement of R&D and networking for biosecurity as a key agenda under "Safe and Secure Society" initiative. Pandemic preparedness was significantly improved after 2009 with the Special Measures Act for crisis management. More recently, the National Institute of Allergy and Infectious Diseases (NIAID) Office of Biodefense Research and Surety has been engaged with Japan in medical research issues involved with biosecurity and biodefense under the U.S. - Japan Framework Initiative for a Safe and Secure Society. As the government engages in these current and future policy activities, understanding the existing biosecurity and biodefense policy, the pharmaceutical companies operating in the biodefense market have considerable opportunities to expand and be prepared for any bioterrorism. The initiatives of governments open a window of opportunities for the firms involved in the biodefense sector.

Moreover, due to factors such as increasing border threats, rising national security concerns, and changing dynamics of warfare, countries such as China, Japan, India in Asia Pacific are inclined towards enhancing their missile weapon store. They are also modernizing their old missiles with the new propulsion system and warheads. Hence, as the threat for biological weapon and nuclear armed ICBM is increasing, governments of various countries are actively funding for biodefense, thereby, positively propelling the Asia Pacific market. Thus, owing to the factors mentioned above are likely to boost the growth of the Biodefense Market in Asia Pacific during the forecast period.

In 2019, the anthrax segment accounted for the largest market share in the Biodefense Market in Asia Pacific. The segment is expected to continue its dominance over the forecast period owing to increasing funding by the governments of other countries to develop and stockpile adequate vaccines against anthrax mainly through a variety of initiatives in Asian countries, such as safe and security initiative , Special Measures Act for Pandemic preparedness, Civilian Protection Act and the Defense Research and Development Establishment (DRDE).

Some of the significant secondary sources for cold plasma equipment included in the report are the World Health Organization (WHO) and the Food and Drug Administration (FDA).

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific biodefense market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific biodefense market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00010409

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Biodefense market - By Product
    • 1.3.2 Asia Pacific Biodefense market - By Country

2. Asia Pacific Biodefense market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Biodefense market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 4.2.1 Biodefense market - Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Biodefense market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Presence of Favourable Government Initiatives
    • 5.1.2 Increase in the Number of Naturally Occurring Outbreaks
    • 5.1.3 Increasing Threat of Biological Weapons and Nuclear Armed ICBM
  • 5.2 Key Market Restraints
    • 5.2.1 Low R&D Funding by Government in Developing and Underdeveloped Economies
  • 5.3 Key Market Opportunities
    • 5.3.1 Increased Adoption of Technologies
  • 5.4 Future Trends
    • 5.4.1 Predictive Analytics to Reshape Biodefense Market
  • 5.5 Impact Analysis

6. Biodefense market - Asia Pacific Analysis

  • 6.1 Asia Pacific Biodefense market Revenue Forecasts and Analysis

7. Asia Pacific Biodefense market Analysis And Forecasts To 2027 - By Product

  • 7.1 Overview
  • 7.2 Asia Pacific Biodefense market, By Product 2019 & 2027 (%)
    • 7.2.1 Asia Pacific Biodefense market Revenue and Forecasts to 2027, By Product (US$ Mn)
  • 7.3 Anthrax
    • 7.3.1 Overview
    • 7.3.2 Asia Pacific Anthrax Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Small pox
    • 7.4.1 Overview
    • 7.4.2 Asia Pacific Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 Botulism
    • 7.5.1 Overview
    • 7.5.2 Asia Pacific Botulism Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.6 Radiation/Nuclear
    • 7.6.1 Overview
    • 7.6.2 Asia Pacific Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Biodefense market Revenue and Forecasts To 2027 - Geographical Analysis

  • 8.1 Asia Pacific Biodefense market Revenue and Forecasts To 2027
    • 8.1.1 Overview
    • 8.1.2 Asia Pacific: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
    • 8.1.3 Asia Pacific: Biodefense Market, by Product, 2018-2027 (USD Million)
    • 8.1.4 Asia Pacific: Biodefense Market, by Country, 2018 & 2027 (%)
    • 8.1.5 China: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.5.1 China: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.5.2 China: Biodefense Market, by Product Type, 2018-2027 (USD Million)
    • 8.1.6 Japan: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.6.1 Japan: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.6.2 Japan: Biodefense Market, by Product Type, 2018-2027 (USD Million)
    • 8.1.7 India: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.7.1 India: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.7.2 India: Biodefense Market, by Product Type, 2018-2027 (USD Million)
    • 8.1.8 South Korea: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.8.1 South Korea: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.8.2 South Korea: Biodefense Market, by Product Type, 2018-2027 (USD Million)
    • 8.1.9 Australia: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.9.1 Australia: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
      • 8.1.9.2 Australia: Biodefense Market, by Product Type, 2018-2027 (USD Million)

9. Impact of Covid-19 Pandemic On Asia Pacific Biodefense Market

  • 9.1 Asia-Pacific: Impact assessment of COVID-19 Pandemic

10. Asia Pacific Biodefense market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Biodefense Market, 2016-2020
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. COMPANY PROFILES

  • 11.1 Bavarian Nordic
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Alnylam Pharmaceuticals, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 SIGA Technologies
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Emergent BioSolutions Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Cleveland Bio Labs
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

LIST OF TABLES

  • Table 1. Asia Pacific Biodefense market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 2. Asia Pacific Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 3. China Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Japan Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. India Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 6. South Korea Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Australia Biodefense Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Recent Inorganic Growth Strategies In The Biodefense Market
  • Table 9. Recent Organic Growth Strategies In The Biodefense Market
  • Table 10. Glossary of Terms, Skin aesthetic devices market

LIST OF FIGURES

  • Figure 1. Biodefense market Segmentation
  • Figure 2. Asia Pacific Biodefense market Overview
  • Figure 3. Anthrax Segment Held Largest Share of Product Segment in Biodefense Market
  • Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Asia Pacific Biodefense market- Leading Country Markets (US$ Mn)
  • Figure 6. Asia Pacific Biodefense market, Industry Landscape
  • Figure 7. Biodefense market - Asia Pacific PEST Analysis
  • Figure 8. Biodefense market Impact Analysis of Drivers and Restraints
  • Figure 9. Asia Pacific Biodefense market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 10. Asia Pacific Biodefense market, By Product 2019 & 2027 (%)
  • Figure 11. Asia Pacific Anthrax Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. Asia Pacific Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 13. Asia Pacific Botulism Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. Asia Pacific Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 15. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 16. Asia Pacific: Biodefense Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 17. Asia Pacific Biodefense Market Revenue and Forecast to 2027 (USD Million)
  • Figure 18. China: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 19. Japan: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 20. India: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 21. South Korea: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 22. Australia: Biodefense Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Impact Of Covid-19 Pandemic In Asia Pacific Country Markets
  • Figure 24. Growth Strategies in the Biodefense Market, 2016-2020
Back to Top